TD Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Hold |
172,078
| – | – | ﹤0.01% | 1092 |
|
|
2025
Q1 | $798K | Sell |
172,078
-48,018
| -22% | -$223K | ﹤0.01% | 1099 |
|
|
2024
Q4 | $1.53M | Buy |
220,096
+26,400
| +14% | +$183K | ﹤0.01% | 1062 |
|
|
2024
Q3 | $1M | Hold |
193,696
| – | – | ﹤0.01% | 1184 |
|
|
2024
Q2 | $724K | Buy |
193,696
+528
| +0.3% | +$1.98K | ﹤0.01% | 1216 |
|
|
2024
Q1 | $1.36M | Hold |
193,168
| – | – | ﹤0.01% | 1116 |
|
|
2023
Q4 | $1.09M | Hold |
193,168
| – | – | ﹤0.01% | 1167 |
|
|
2023
Q3 | $925K | Buy |
193,168
+76,550
| +66% | +$367K | ﹤0.01% | 1163 |
|
|
2023
Q2 | $799K | Sell |
116,618
-24,236
| -17% | -$166K | ﹤0.01% | 1173 |
|
|
2023
Q1 | $1.1M | Hold |
140,854
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q4 | $1.07M | Hold |
140,854
| – | – | ﹤0.01% | 1127 |
|
|
2022
Q3 | $1.1M | Hold |
140,854
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q2 | $1.36M | Hold |
140,854
| – | – | ﹤0.01% | 1120 |
|
|
2022
Q1 | $1.98M | Buy |
140,854
+8,678
| +7% | +$122K | ﹤0.01% | 1089 |
|
|
2021
Q4 | $2.7M | Buy |
132,176
+93,412
| +241% | +$1.91M | ﹤0.01% | 1059 |
|
|
2021
Q3 | $864K | Hold |
38,764
| – | – | ﹤0.01% | 1286 |
|
|
2021
Q2 | $950K | Buy |
+38,764
| New | +$950K | ﹤0.01% | 1276 |
|